Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Dominance, Cerebral (drug effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dominance, Cerebral < Dominance, Cerebral (drug effects) < Dominance, Cerebral (genetics)  Facettes :

List of bibliographic references indexed by Dominance, Cerebral (drug effects)

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
004E98 (1998) John C. Detoledo [États-Unis] ; Dow [États-Unis]Sternomastoid function during hemispheric suppression by amytal: Insights into the inputs to the spinal accessory nerve nucleus
004E99 (1998) P. Van Den Munckhof [États-Unis] ; F. A. Lenz [États-Unis] ; T. N. Chase [États-Unis] ; L. Verhagen Metman [États-Unis]Square‐wave action dystonia in Parkinson's disease
004F34 (1998) Elaine J. Skalabrin [États-Unis] ; Edward R. Laws Jr. [États-Unis] ; James P. Bennett Jr. [États-Unis]Pallidotomy improves motor responses and widens the levodopa therapeutic window in Parkinson's disease
004F76 (1998) Paul Krack [France] ; Pierre Pollak [France] ; Patricia Limousin [France] ; Dominique Hoffmann [France] ; Abdelhamid Benazzouz [France] ; Alim-Louis Benabid [France]Inhibition of levodopa effects by internal pallidal stimulation
005048 (1998) Maurer [Allemagne] ; Thomas Grunwald [Allemagne] ; Christian E. Elger [Allemagne]Clozapine treatment of delayed‐onset paroxysmal hemidystonia
005065 (1998) Dethy [Belgique] ; Nadège Van Blercom [Belgique] ; Philippe Damhaut [Belgique] ; David Wikler [Belgique] ; Jerzy Hildebrand [Belgique] ; Serge Goldman [Belgique]Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism
005599 (1996) B. Zeng [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6‐Hydroxydopamine–Lesioned rat striatum parallels functional recovery
005713 (1996) Abdelhamid Benazzouz [France] ; Thomas Boraud [France] ; Jean Féger [France] ; Pierre Burbaud [France] ; Bernard Bioulac [France] ; Christian Gross [France]Alleviation of experimental hemiparkinsonism by high‐frequency stimulation of the subthalamic nucleus in primates: A comparison with L‐dopa treatment
005719 (1996) Limousin [France] ; Pierre Pollak [France] ; Dominique Hoffmann [France] ; Abdelhamid Benazzouz [France] ; Jean Edmond Perret [France] ; Alim-Louis Benabid [France]Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients
005897 (1995) Lang [Canada]Hemiatrophy, juvenile‐onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult‐onset hemiparkinsonism: The spectrum of hemiparkinsonism‐hemiatrophy syndrome
005B26 (1994) Belluzzi [États-Unis] ; E. F. Domino [États-Unis] ; J. M. May [États-Unis] ; K. S. Bankiewicz [États-Unis] ; D. A. Mcafee [États-Unis]N‐0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease
005D25 (1993) S. B. Blunt [Royaume-Uni] ; Jenner ; C. D. Marsden [Royaume-Uni]Suppressive effect of L‐dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6‐hydroxydopamine
005D40 (1993) Mazzucchi [Italie] ; E. Sinforiani [Italie] ; L. Ludovico [Italie] ; M. Turla [Italie] ; C. Pacchetti [Italie] ; R. Brianti [Italie] ; M. Parma [Italie] ; G. Nappi [Italie]Reaction time responses in parkinsonian and hemiparkinsonian patients
006156 (1991) T. Z. Aziz [Royaume-Uni] ; D. Peggs [Royaume-Uni] ; M. A. Sambrook [Royaume-Uni] ; Crossman [Royaume-Uni]Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primate
006199 (1991) Jonathan M. Brotchie [Royaume-Uni] ; Mitchell [Royaume-Uni] ; Michael A. Sambrook [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni]Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dominance, Cerebral (drug effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dominance, Cerebral (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dominance, Cerebral (drug effects)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024